What is Redlen Technologies?
Redlen Technologies Inc. is a specialized developer of advanced radiation imaging and detection systems. At the core of its product suite is the proprietary Cadmium Zinc Telluride (CZT) semiconductor sensor, a technology that enables superior accuracy in high-resolution imaging. The company serves a diverse array of high-stakes sectors, including medical diagnostics, security screening, and industrial non-destructive testing. By focusing on low-dose imaging solutions, Redlen addresses the dual requirements of safety and diagnostic clarity, positioning itself as a vital component in the global healthcare and security infrastructure supply chain.
How much funding has Redlen Technologies raised?
Redlen Technologies has raised a total of $17.5M across 4 funding rounds:
Other Financing Round
$1.7M
Other Financing Round
$7.8M
Private Equity
$5.5M
Series A
$2.4M
Other Financing Round (2004): $1.7M with participation from Yaletown Partners
Other Financing Round (2010): $7.8M led by BC Advantage Funds and GrowthWorks Capital
Private Equity (2014): $5.5M supported by Pangaea Ventures
Series A (2015): $2.4M featuring Pangaea Ventures
Key Investors in Redlen Technologies
Pangaea Ventures
A leading venture capital firm specializing in hard tech, focusing on investments in start-up companies that utilize advancements in materials, chemistry, and biology to tackle significant global challenges.
GrowthWorks Capital
A Canadian venture capital firm investing in early-stage technology companies with a long history of supporting regional innovation and industrial growth.
Yaletown Partners
An investment firm focused on transforming industries through technology, specializing in driving growth for innovative companies at the emerging stage.
What's next for Redlen Technologies?
With a history of successful financing rounds, Redlen Technologies is well-positioned to capitalize on the increasing demand for high-fidelity imaging sensors. The company's strategic focus will likely involve expanding its market share in the medical imaging sector while simultaneously enhancing its footprint in global security screening. As the industry shifts toward more precise, data-driven diagnostic tools, Redlen's commitment to R&D and semiconductor innovation will be the primary driver of its future valuation. The firm is expected to leverage its current capital position to accelerate the commercialization of next-generation sensors, further cementing its status as a cornerstone of the hard tech ecosystem.
See full Redlen Technologies company page
